Storage and Handling of BPC-157 Powder Proper storage and handling of BPC-157 powder are crucial to maintain its stability and efficacy: Store the powder in a cool, dry place, preferably at -20C or lower
Contact your GP or diabetes specialist nurse if you experience: Persistent nausea or vomiting lasting more than a few days, particularly if it prevents you from taking medications or maintaining hydration Inability to eat or drink adequately due to early satiety or abdominal discomfort Rapid or unexplained weight loss exceeding expected therapeutic effects Abdominal pain or distension Vomiting of food consumed several hours previously Worsening blood glucose control despite medication adherence Seek urgent medical attention (contact NHS 111 or attend A&E) if you develop: Severe, persistent vomiting with inability to keep down fluids Signs of dehydration (dark urine, dizziness, confusion, reduced urine output) Severe abdominal pain, especially if radiating to the back and accompanied by vomiting (which could indicate pancreatitis) Vomiting blood or material that looks like coffee grounds Black, tarry stools Your healthcare provider may adjust your treatment plan by reducing the Ozempic dose, temporarily discontinuing the medication, or switching to an alternative diabetes therapy
Tirzepatide users in the SURMOUNT-1 trial lost up to 22.5% of body weight, substantially more than semaglutide STEP trial results
Our team can assist with verifying your coverage and answering questions about your plan
